Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 11
- Uncategorized
Cannabis Companies Demand Retail Licences In New York
In a letter to New York’s governor, four cannabis companies have highlighted the mess of New York’s adult-use cannabis programme rollout, calling on the state to issue retail licences.
- Uncategorized
California Doubles Funding for Cannabis Retail Grants
California’s Department of Cannabis Control (DCC) has announced it has doubled funding for the Phase II round of its Local Jurisdiction Retail Access Grant programme.
- Uncategorized
North Carolina Stop Pot Act Would Slash Funding for Native Tribes
The new ‘Stop Pot Act’ introduced in North Carolina by Congressman Chuck Edwards would see funding cut for states and native tribes that legalise recreational cannabis.
- Uncategorized
How cannabis rescheduling could create new opportunities for banking
Last week, the U.S Department of Health and Human Services (HHS) urged the Drug Enforcement Administration (DEA) to reclassify cannabis from Schedule I to Schedule III under federal law.
- Uncategorized
Connecticut Launches Social Equity Fund for Cannabis Businesses
Connecticut has officially launched its Canna-Business Revolving Loan Fund (CBRLF).
- Uncategorized
Decibel Expands Global Footprint into UK Medical Cannabis Market
Canada-based Decibel is expanding its global footprint through a new supply agreement to provide premium dried medical cannabis flower to the United Kingdom’s 4C LABS. 4C Labs is a healthcare, technology and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis-based medicinal products in the UK.
- Uncategorized
Stocks Rally Following Leaked Cannabis Rescheduling Letter
Cannabis stocks are rallying after a letter was leaked to Bloomberg on Wednesday revealing that The U.S Department of Health and Human Services (HHS) has recommended the Drug Enforcement Administration (DEA) reclassify cannabis from Schedule I to Schedule III under federal law.
- Uncategorized
HHS Recommends Reclassifying Cannabis from Schedule I to Schedule III Under Federal Law
The U.S Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be reclassified from Schedule I to Schedule III under federal law.
- Uncategorized
Ohio Could See Cannabis Legalisation As New Survey Shows Resounding Bipartisan Support
A new survey has shown resounding bipartisan support for cannabis legalisation in Ohio.
- Uncategorized
New York Brings Cannabis Licensing to Complete Halt
New York has seen its cannabis licensing process draw to a complete halt after a temporary injunction was implemented on New York’s Conditional Adult-Use Retail Dispensary (CAURD) scheme.
- Uncategorized
Georgia Votes to Approve Three New Medical Cannabis Dispensaries
At a recent meeting of the Georgia Access to Medical Cannabis Commission, the board voted to approve three new cannabis dispensaries.
- Uncategorized
South Dakota Doubles Number of Medical Cards Since 2021
South Dakota’s medical cannabis card programme has almost doubled the number of cards granted since it began in 2021.
